110 related articles for article (PubMed ID: 11211869)
1. Identification, expression, and nuclear location of murine Mage-b2 protein, a tumor-associated antigen.
Lee JH; Sung BW; Youn HJ; Park JH
Mol Cells; 2000 Dec; 10(6):647-53. PubMed ID: 11211869
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
Carrel S; Schreyer M; Spagnoli G; Cerottini JC; Rimoldi D
Int J Cancer; 1996 Jul; 67(3):417-22. PubMed ID: 8707418
[TBL] [Abstract][Full Text] [Related]
3. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.
Chen YT; Stockert E; Chen Y; Garin-Chesa P; Rettig WJ; van der Bruggen P; Boon T; Old LJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1004-8. PubMed ID: 8302824
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
Schultz-Thater E; Piscuoglio S; Iezzi G; Le Magnen C; Zajac P; Carafa V; Terracciano L; Tornillo L; Spagnoli GC
Int J Cancer; 2011 Sep; 129(5):1137-48. PubMed ID: 21710496
[TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Zhuang R; Zhu Y; Fang L; Liu XS; Tian Y; Chen LH; Ouyang WM; Xu XG; Jian JL; Güre AO; Fortunato S; Ritter G; Old LJ; Simpson AJ; Chen YT; Jin B; Jungbluth AA
Cancer Immun; 2006 Apr; 6():7. PubMed ID: 16594646
[TBL] [Abstract][Full Text] [Related]
6. Identification and intracellular location of MAGE-3 gene product.
Kocher T; Schultz-Thater E; Gudat F; Schaefer C; Casorati G; Juretic A; Willimann T; Harder F; Heberer M; Spagnoli GC
Cancer Res; 1995 Jun; 55(11):2236-9. PubMed ID: 7757970
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
Huang LQ; Brasseur F; Serrano A; De Plaen E; van der Bruggen P; Boon T; Van Pel A
J Immunol; 1999 Jun; 162(11):6849-54. PubMed ID: 10352307
[TBL] [Abstract][Full Text] [Related]
8. Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes.
De Backer O; Verheyden AM; Martin B; Godelaine D; De Plaen E; Brasseur R; Avner P; Boon T
Genomics; 1995 Jul; 28(1):74-83. PubMed ID: 7590750
[TBL] [Abstract][Full Text] [Related]
9. Hypertonicity induction of melanoma antigen, a tumor-associated antigen.
Park JH; Lee SW
Mol Cells; 2002 Apr; 13(2):288-95. PubMed ID: 12018852
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma.
Zuber M; Spagnoli GC; Kocher T; Lüscher U; Schaefer C; Noppen C; Gudat F; Harder F; Heberer M
Eur Surg Res; 1997; 29(5):403-10. PubMed ID: 9323494
[TBL] [Abstract][Full Text] [Related]
11. cDNA and protein characterization of human MAGE-10.
Rimoldi D; Salvi S; Reed D; Coulie P; Jongeneel VC; De Plaen E; Brasseur F; Rodriguez AM; Boon T; Cerottini JC
Int J Cancer; 1999 Sep; 82(6):901-7. PubMed ID: 10446460
[TBL] [Abstract][Full Text] [Related]
12. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
[TBL] [Abstract][Full Text] [Related]
13. Expression of MAGE tumor-associated antigen in thyroid carcinomas.
Milkovic M; Sarcevic B; Glavan E
Endocr Pathol; 2006; 17(1):45-52. PubMed ID: 16760579
[TBL] [Abstract][Full Text] [Related]
14. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.
Sarcevic B; Spagnoli GC; Terracciano L; Schultz-Thater E; Heberer M; Gamulin M; Krajina Z; Oresic T; Separovic R; Juretic A
Oncology; 2003; 64(4):443-9. PubMed ID: 12759544
[TBL] [Abstract][Full Text] [Related]
16. MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus.
Hoftman AD; Tai LQ; Tze S; Seligson D; Gatti RA; McCurdy DK
J Rheumatol; 2008 Dec; 35(12):2430-8. PubMed ID: 19004030
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MAGE-3 derived synthetic peptide as a human lung cancer antigen recognized by cytotoxic T lymphocytes.
Eifuku R; Takenoyama M; Yoshino I; Imahayashi S; So T; Yasuda M; Sugaya M; Yasumoto K
Int J Clin Oncol; 2001 Feb; 6(1):34-9. PubMed ID: 11706525
[TBL] [Abstract][Full Text] [Related]
18. A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.
Zhang Y; Chaux P; Stroobant V; Eggermont AM; Corthals J; Maillère B; Thielemans K; Marchand M; Boon T; Van Der Bruggen P
J Immunol; 2003 Jul; 171(1):219-25. PubMed ID: 12817001
[TBL] [Abstract][Full Text] [Related]
19. MAGE-A9 mRNA and protein expression in bladder cancer.
Picard V; Bergeron A; Larue H; Fradet Y
Int J Cancer; 2007 May; 120(10):2170-7. PubMed ID: 17290406
[TBL] [Abstract][Full Text] [Related]
20. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
